How Much Upside is Left in Keros Therapeutics (KROS)? Wall Street Analysts Think 34.24%

Shares of Keros Therapeutics, Inc. (KROS) have gained 14.1% over the past four weeks to close the last trading session at $17.32, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $23.25 indicates a potential upside of 34.2%.The average comprises eight short-term price targets ranging from a low of $16.00 to a high of $35.00, with a standard deviation of $5.95. While the lowest es ...